{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:39:48Z","timestamp":1790739588869,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Follicular lymphoma in situ (FLIS) was first described nearly a decade ago, but its clinical significance remains uncertain. We reevaluated our original series and more recently diagnosed cases to develop criteria for the distinction of FLIS from partial involvement by follicular lymphoma (PFL). A total of 34 cases of FLIS were identified, most often as an incidental finding in a reactive lymph node. Six of 34 patients had prior or concurrent FL, and 5 of 34 had FLIS composite with another lymphoma. Of patients with negative staging at diagnosis and available follow-up (21 patients), only one (5%) developed FL (follow-up: median, 41 months; range, 10-118 months). Follow-up was not available in 2 cases. Fluorescence in situ hybridization for BCL2 gene rearrangement was positive in all 17 cases tested. PFL patients were more likely to develop FL, diagnosed in 9 of 17 (53%) who were untreated. Six patients with PFL were treated with local radiation therapy (4) or rituximab (2) and remained with no evidence of disease. FLIS can be reliably distinguished from PFL and has a very low rate of progression to clinically significant FL. FLIS may represent the tissue counterpart of circulating t(14;18)-positive B cells.<\/jats:p>","DOI":"10.1182\/blood-2011-05-355255","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T20:35:21Z","timestamp":1311021321000},"page":"2976-2984","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":132,"title":["Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma"],"prefix":"10.1182","volume":"118","author":[{"given":"Armin G.","family":"Jegalian","sequence":"first","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska C.","family":"Eberle","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana D.","family":"Pack","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Mirvis","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"15","key":"2019111806390488800_B1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2019111806390488800_B2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma.","volume":"89","author":"Non-Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"key":"2019111806390488800_B3","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"issue":"23","key":"2019111806390488800_B4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin's lymphomas.","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"issue":"9383","key":"2019111806390488800_B5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","article-title":"Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial.","volume":"362","author":"Ardeshna","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"2019111806390488800_B6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hon.882","article-title":"Low dose radiotherapy in indolent lymphomas, enough is enough.","volume":"27","author":"Haas","year":"2009","journal-title":"Hematol Oncol"},{"key":"2019111806390488800_B7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/10428190802311409","article-title":"Refining the treatment of follicular lymphoma.","volume":"49","author":"Buske","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2019111806390488800_B8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1200\/JCO.2004.10.086","article-title":"Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.","volume":"22","author":"Advani","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4720","key":"2019111806390488800_B9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"12","key":"2019111806390488800_B10","first-page":"2271","article-title":"Bcl-2\/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.","volume":"6","author":"Limpens","year":"1991","journal-title":"Oncogene"},{"issue":"19","key":"2019111806390488800_B11","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1073\/pnas.91.19.8910","article-title":"BCL2 translocation frequency rises with age in humans.","volume":"91","author":"Liu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111806390488800_B12","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals.","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood"},{"issue":"13","key":"2019111806390488800_B13","first-page":"2876","article-title":"Frequent detection of bcl-2\/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay.","volume":"55","author":"Ji","year":"1995","journal-title":"Cancer Res"},{"issue":"2","key":"2019111806390488800_B14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2001.19.2.420","article-title":"Frequency of the Bcl-2\/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.","volume":"19","author":"Summers","year":"2001","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111806390488800_B15","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.2003.07.070","article-title":"PCR-detectable nonneoplastic Bcl-2\/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy.","volume":"21","author":"Ladetto","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111806390488800_B16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.leukres.2005.10.001","article-title":"The bcl-2\/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.","volume":"30","author":"Schmitt","year":"2006","journal-title":"Leuk Res"},{"key":"2019111806390488800_B17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jncimonographs\/lgn005","article-title":"Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals.","volume":"39","author":"Dolken","year":"2008","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"2019111806390488800_B18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jnci\/87.3.223","article-title":"Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers.","volume":"87","author":"Bell","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2019111806390488800_B19","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/0008-5472.CAN-03-3604","article-title":"Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides.","volume":"64","author":"Roulland","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"2019111806390488800_B20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood.V98.2.486","article-title":"Low frequency of BCL-2\/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals.","volume":"98","author":"Yasukawa","year":"2001","journal-title":"Blood"},{"issue":"4","key":"2019111806390488800_B21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1200\/JCO.1996.14.4.1333","article-title":"BCL-2\/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases.","volume":"14","author":"Dolken","year":"1996","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111806390488800_B22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404035","article-title":"Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals.","volume":"20","author":"Roulland","year":"2006","journal-title":"Leukemia"},{"issue":"7","key":"2019111806390488800_B23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1084\/jem.20082842","article-title":"Agricultural pesticide exposure and the molecular connection to lymphomagenesis.","volume":"206","author":"Agopian","year":"2009","journal-title":"J Exp Med"},{"issue":"9","key":"2019111806390488800_B24","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2019111806390488800_B25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.yexmp.2007.03.001","article-title":"In situ follicular lymphoma with a 14;18 translocation diagnosed by a multimodal approach.","volume":"83","author":"Sotomayor","year":"2007","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"2019111806390488800_B26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/1066896909350174","article-title":"In situ follicular lymphoma associated with progressive transformation of the germinal center.","volume":"19","author":"Handa","year":"2011","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"2019111806390488800_B27","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/leu.2009.9","article-title":"In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2\/IGH fusion gene in blood and lymph node.","volume":"23","author":"Cheung","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"2019111806390488800_B28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/AJCPF9V8XRDYWTIR","article-title":"Follicular lymphoma of the spleen: multiparameter analysis of 16 cases.","volume":"131","author":"Howard","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2019111806390488800_B29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1309\/AJCP5RT4MRSDGKSX","article-title":"Coexisting follicular and mantle cell lymphoma with each having an in situ component: a novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma.","volume":"133","author":"Roullet","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2019111806390488800_B30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2559.2010.03529.x","article-title":"Intrafollicular neoplasia\/in situ follicular lymphoma: review of a series of 13 cases.","volume":"56","author":"Montes-Moreno","year":"2010","journal-title":"Histopathology"},{"issue":"12","key":"2019111806390488800_B31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.pas.0000173233.29741.38","article-title":"Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage.","volume":"29","author":"Adam","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"19","key":"2019111806390488800_B32","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111806390488800_B33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/jcp.45.9.770","article-title":"Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms.","volume":"45","author":"Ramasamy","year":"1992","journal-title":"J Clin Pathol"},{"key":"2019111806390488800_B34","first-page":"35","article-title":"Fluorescence in situ hybridization: application in cancer research and clinical diagnostics.","volume":"50","author":"Pack","year":"2001","journal-title":"Methods Mol Med"},{"issue":"3","key":"2019111806390488800_B35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/00313021003631296","article-title":"Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.","volume":"42","author":"Masir","year":"2010","journal-title":"Pathology"},{"issue":"4","key":"2019111806390488800_B36","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1463-1318.2005.00936.x","article-title":"The adenoma carcinoma sequence: an indoctrinated model for tumorigenesis, but is it always a clinical reality?","volume":"8","author":"Smith","year":"2006","journal-title":"Colorectal Dis"},{"issue":"3","key":"2019111806390488800_B37","first-page":"401","article-title":"Follicular lymphomas: possibility that they are benign tumors of the lymphoid system.","volume":"70","author":"Jaffe","year":"1983","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2019111806390488800_B38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.humpath.2008.05.017","article-title":"Composite mantle cell and follicular lymphoma: a case report.","volume":"40","author":"Ilgenfritz","year":"2009","journal-title":"Hum Pathol"},{"issue":"5","key":"2019111806390488800_B39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00428-006-0158-9","article-title":"Molecular characterization of composite mantle cell and follicular lymphoma.","volume":"448","author":"Zamo","year":"2006","journal-title":"Virchows Arch"},{"issue":"3","key":"2019111806390488800_B40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.1689","article-title":"Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation.","volume":"205","author":"Schraders","year":"2005","journal-title":"J Pathol"},{"issue":"6","key":"2019111806390488800_B41","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)65443-0","article-title":"Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas: a molecular analysis using laser capture microdissection.","volume":"154","author":"Fend","year":"1999","journal-title":"Am J Pathol"},{"issue":"15","key":"2019111806390488800_B42","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1182\/blood-2010-10-299628","article-title":"How I treat: diagnosing and managing \u201cin situ\u201d lymphoma.","volume":"117","author":"Carbone","year":"2011","journal-title":"Blood"},{"issue":"6306","key":"2019111806390488800_B43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18).","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"issue":"11","key":"2019111806390488800_B44","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases.","volume":"29","author":"Schmatz","year":"2011","journal-title":"J Clin Oncol"},{"key":"2019111806390488800_B45","first-page":"5547S","article-title":"Antigen selection in human lymphomagenesis.","volume":"52","author":"Bahler","year":"1992","journal-title":"Cancer Res"},{"issue":"4","key":"2019111806390488800_B46","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.176.4.1137","article-title":"Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection.","volume":"176","author":"Zelenetz","year":"1992","journal-title":"J Exp Med"},{"issue":"6","key":"2019111806390488800_B47","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.V99.6.2192","article-title":"Tumor cell dissemination in follicular lymphoma.","volume":"99","author":"Oeschger","year":"2002","journal-title":"Blood"},{"issue":"9","key":"2019111806390488800_B48","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403844","article-title":"Clonal selection in the bone marrow involvement of follicular lymphoma.","volume":"19","author":"Bognar","year":"2005","journal-title":"Leukemia"},{"issue":"4","key":"2019111806390488800_B49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.820","article-title":"Relative distribution of tumour cells and reactive cells in follicular lymphoma.","volume":"193","author":"Su","year":"2001","journal-title":"J Pathol"},{"issue":"19","key":"2019111806390488800_B50","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/11\/2976\/1342383\/zh803711002976.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/11\/2976\/1342383\/zh803711002976.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T06:39:34Z","timestamp":1574059174000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/11\/2976\/28482\/Follicular-lymphoma-in-situ-clinical-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-05-355255","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,15]]}}}